CA3287863A1 - Préparation pharmaceutique contenant une protéine de fusion glp-1 et son utilisation - Google Patents

Préparation pharmaceutique contenant une protéine de fusion glp-1 et son utilisation

Info

Publication number
CA3287863A1
CA3287863A1 CA3287863A CA3287863A CA3287863A1 CA 3287863 A1 CA3287863 A1 CA 3287863A1 CA 3287863 A CA3287863 A CA 3287863A CA 3287863 A CA3287863 A CA 3287863A CA 3287863 A1 CA3287863 A1 CA 3287863A1
Authority
CA
Canada
Prior art keywords
glp
pharmaceutical preparation
fusion protein
math
months
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3287863A
Other languages
English (en)
Inventor
Qinghua Wang
Original Assignee
Guangzhou Innogen Pharmaceutical Group Co Ltd
Shanghai Innogen Biomedical Engineering Co Ltd
Shanghai Innogen Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Innogen Pharmaceutical Group Co Ltd, Shanghai Innogen Biomedical Engineering Co Ltd, Shanghai Innogen Pharmaceutical Technology Co Ltd filed Critical Guangzhou Innogen Pharmaceutical Group Co Ltd
Publication of CA3287863A1 publication Critical patent/CA3287863A1/fr
Pending legal-status Critical Current

Links

CA3287863A 2023-03-30 2024-03-29 Préparation pharmaceutique contenant une protéine de fusion glp-1 et son utilisation Pending CA3287863A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202310331480.9 2023-03-30
CNPCT/CN2023/101978 2023-06-21
CN202410366079.3 2024-03-27

Publications (1)

Publication Number Publication Date
CA3287863A1 true CA3287863A1 (fr) 2026-01-19

Family

ID=

Similar Documents

Publication Publication Date Title
US12247058B2 (en) Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof
RU2741345C2 (ru) Белки с двойной функцией и содержащая их фармацевтическая композиция
ES3023833T3 (en) Pharmaceutical composition for preventing or treating hepatitis, hepatic fibrosis, and hepatic cirrhosis comprising fusion proteins
CN117327658A (zh) 一种重组细胞及其构建方法和应用
US20250376498A1 (en) Fusion proteins comprising an improved glp-1 receptor agonist and uses thereof
CN105792839A (zh) 用于治疗的胰岛素样生长因子拟似物
CA3287863A1 (fr) Préparation pharmaceutique contenant une protéine de fusion glp-1 et son utilisation
EP4691496A1 (fr) Préparation pharmaceutique contenant une protéine de fusion glp-1 et son utilisation
CN117327190A (zh) 一种改进的glp-1受体激动剂和融合蛋白及其应用
RU2795548C2 (ru) Фармацевтическая композиция для предотвращения или лечения гепатита, фиброза печени и цирроза печени, включающая слитые белки
KR20260005268A (ko) 당뇨병 치료
HK40012348A (en) Pharmaceutical composition for preventing or treating hepatitis, hepatic fibrosis, and hepatic cirrhosis comprising fusion proteins